Alvotech (OISE:ALVO) Asset Impairment Charge : kr0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Alvotech Asset Impairment Charge?

Alvotech's Asset Impairment Charge for the three months ended in Mar. 2024 was kr0 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 was kr0 Mil.

Alvotech Asset Impairment Charge Historical Data

The historical data trend for Alvotech's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alvotech Asset Impairment Charge Chart

Alvotech Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

294.42

836.39

378.68

3,202.32

Alvotech Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Asset Impairment Charge	Get a 7-Day Free Trial									-	-	-	-	-

Alvotech Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0 Mil.

Alvotech Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of Alvotech's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

Alvotech (OISE:ALVO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alvotech (OISE:ALVO) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

ALVO:USA Z45:Germany

Address

9, rue de Bitbourg, Luxembourg, LUX, L-1273

Website

https://www.alvotech.com

Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.